STOCKHOLM – April 29, 2026 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, today announces significant progress in its UK market entry and continued sales […]

STOCKHOLM – February 25, 2026 – Inify Laboratories, a unique laboratory service that provides diagnostics within pathology, reports continued sales growth in the fourth quarter of 2025. Significant progress has […]

In connection with the publication of the company's Q3 2025 Financial Report, it was discovered that the amount for personnel costs in the parent company's income statement was incorrect. The […]

STOCKHOLM – August 27, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to deliver solid sales growth of 54% in the second quarter, […]

STOCKHOLM – April 30, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continued to deliver sales growth and positive margins in Sweden, alongside steady […]

STOCKHOLM – February 26, 2025 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, saw sales grow by 60% compared to the previous quarter, and 472% […]

STOCKHOLM – October 23, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, has after extensive market mapping decided to establish operations in the United […]

STOCKHOLM – August 21, 2024 – Inify Laboratories, a unique laboratory service that provides cancer diagnostics within pathology, continues to deliver strong growth, with sales of SEK 3.6 million in […]